Literature DB >> 27352093

Causes of macrocytic anemia among 628 patients: mean corpuscular volumes of 114 and 130 fL as critical markers for categorization.

Natsuko Takahashi1, Junichi Kameoka2, Naoto Takahashi3, Yoshiko Tamai4, Kazunori Murai5,6, Riko Honma7, Hideyoshi Noji8, Hisayuki Yokoyama9, Yasuo Tomiya10, Yuichi Kato11, Kenichi Ishizawa11, Shigeki Ito5, Yoji Ishida5, Kenichi Sawada3, Hideo Harigae1.   

Abstract

There have been no studies on the distribution of causes of macrocytic anemia with respect to mean corpuscular volume (MCV) cutoff values. We retrospectively investigated the causes of macrocytic anemia (MCV ≥100 fL) among 628 patients who visited the outpatient hematology clinic in Tohoku University Hospital. To ensure data validity, we also analyzed data from 307 patients in eight other hospitals in the Tohoku district. The leading causes of macrocytic anemia (number of patients, %) were myelodysplastic syndromes (121, 19.3 %), suspected bone marrow failure syndromes (BMF; 74, 11.8 %), aplastic anemia (51, 8.1 %), plasma cell dyscrasia (45, 7.2 %), and vitamin B12 deficiency (40, 6.4 %) in Tohoku University Hospital. We made three primary findings as follows. First, the most common cause of macrocytic anemia is BMF. Second, lymphoid and solid malignancies are also common causes of macrocytosis. Third, macrocytic anemia may be classified into three groups: Group 1 (megaloblastic anemia and medications), which can exceed MCV 130 fL; Group 2 (alcoholism/liver disease, BMF, myeloid malignancy, and hemolytic anemia), which can exceed MCV 114 fL; and Group 3 (lymphoid malignancy, chronic renal failure, hypothyroidism, and solid tumors), which does not exceed MCV 114 fL. These conclusions were supported by the results from eight other hospitals.

Entities:  

Keywords:  Bone marrow failure syndromes; MCV; Macrocytic anemia; Megaloblastic anemia; Solid tumors

Mesh:

Year:  2016        PMID: 27352093     DOI: 10.1007/s12185-016-2043-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  26 in total

1.  MACROCYTOSIS OF THE ERYTHROCYTES. A PRELIMINARY REPORT.

Authors:  P G HATTERSLEY
Journal:  JAMA       Date:  1964-09-28       Impact factor: 56.272

Review 2.  Megaloblastic anemia and other causes of macrocytosis.

Authors:  Florence Aslinia; Joseph J Mazza; Steven H Yale
Journal:  Clin Med Res       Date:  2006-09

Review 3.  A practical approach to the differential diagnosis and evaluation of the adult patient with macrocytic anemia.

Authors:  G Colon-Otero; D Menke; C C Hook
Journal:  Med Clin North Am       Date:  1992-05       Impact factor: 5.456

Review 4.  Red cell indices in classification and treatment of anemias: from M.M. Wintrobes's original 1934 classification to the third millennium.

Authors:  Carlo Brugnara; Narla Mohandas
Journal:  Curr Opin Hematol       Date:  2013-05       Impact factor: 3.284

5.  Myelodysplastic Syndromes in the Elderly: Treatment Options and Personalized Management.

Authors:  Sonja Burgstaller; Petra Wiesinger; Reinhard Stauder
Journal:  Drugs Aging       Date:  2015-11       Impact factor: 3.923

6.  High mean red cell volume: its incidence and significance in routine haematology.

Authors:  R J Davidson; P J Hamilton
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

7.  Macrocytosis, a new predictor for esophageal squamous cell carcinoma in Japanese alcoholic men.

Authors:  Akira Yokoyama; Tetsuji Yokoyama; Taro Muramatsu; Tai Omori; Sachio Matsushita; Susumu Higuchi; Katsuya Maruyama; Hiromasa Ishii
Journal:  Carcinogenesis       Date:  2003-08-29       Impact factor: 4.944

8.  Macrocytosis as a consequence of alcohol abuse among patients in general practice.

Authors:  K Seppä; P Laippala; M Saarni
Journal:  Alcohol Clin Exp Res       Date:  1991-10       Impact factor: 3.455

9.  Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study.

Authors:  Karthik K Tennankore; Steven D Soroka; Kenneth A West; Bryce A Kiberd
Journal:  BMC Nephrol       Date:  2011-05-11       Impact factor: 2.388

10.  Prevalence and possible causes of anemia in the elderly: a cross-sectional analysis of a large European university hospital cohort.

Authors:  Veronika Bach; Guenter Schruckmayer; Ines Sam; Georg Kemmler; Reinhard Stauder
Journal:  Clin Interv Aging       Date:  2014-07-22       Impact factor: 4.458

View more
  5 in total

Review 1.  Etanercept-induced leukemia: could increased mean corpuscular volume be a predictor of hematologic malignancy?

Authors:  Döndü Üsküdar Cansu; Hava Üsküdar Teke; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2017-03-02       Impact factor: 2.631

2.  Impact of splicing factor mutations on clinical features in patients with myelodysplastic syndromes.

Authors:  Naoki Shingai; Yuka Harada; Hiroko Iizuka; Yosuke Ogata; Noriko Doki; Kazuteru Ohashi; Masao Hagihara; Norio Komatsu; Hironori Harada
Journal:  Int J Hematol       Date:  2018-10-23       Impact factor: 2.490

3.  A prospective cohort examination of haematological parameters in relation to cancer death and incidence: the Busselton Health Study.

Authors:  Niwansa Adris; Anita Chai Geik Chua; Matthew William Knuiman; Mark Laurence Divitini; Debbie Trinder; John Kevin Olynyk
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

4.  Double Robertsonian translocations in an infertile patient with macrocytic anemia: a case report.

Authors:  Ramakrishnan Sasi; Jamie Senft; Michelle Spruill; Soham Rej; Peter L Perrotta
Journal:  Mol Cytogenet       Date:  2020-04-16       Impact factor: 2.009

5.  Inverse Relationship between Mean Corpuscular Volume and T-Score in Chronic Dialysis Patients.

Authors:  Ming-Hsiu Chiang; Chih-Yu Yang; Yi-Jie Kuo; Chung-Yi Cheng; Shu-Wei Huang; Yu-Pin Chen
Journal:  Medicina (Kaunas)       Date:  2022-03-30       Impact factor: 2.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.